🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "targeted action to tackle household expense challenges" in the forthcoming Budget.

During an interview with media outlets, she emphasized that lowering inflation is a shared duty of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven developed nations this calendar year and next.

Potential Utility Bill Interventions

Sources suggest the government could take action to bring down energy bills, such as by cutting the present 5% level of value-added tax charged on energy.

A further possibility is to cut some of the policy costs presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much scope there is for these measures.

The view from the majority of experts is that the Chancellor will have to introduce tax rises or expenditure reductions in order to meet her self-imposed borrowing rules.

Earlier on the same day, analysis showed there was a twenty-two billion pound gap for the chancellor to fill, which is at the more modest range of expectations.

"There's a collective job between the Bank of England and the government to bear down further on some of the causes of price increases," the Chancellor told reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Commitments and Global Concerns

While much of the focus has been on probable tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her vow to manifesto promises not to raise rates on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with increasing international and trade concerns for the fiscal tax moves, probably to be directed on those "with the broadest shoulders."

International Trade Disputes

Commenting on concerns about the UK's trade ties with China she said: "Our national security always are paramount."

Recent announcement by Chinese authorities to increase trade restrictions on rare earths and other materials that are crucial for advanced tech production led US President Donald Trump to suggest an additional 100% tariff on imports from China, increasing the risk of an full-scale commercial conflict between the two global powers.

The American finance chief described China's decision "commercial pressure" and "a global supply chain control attempt."

Questioned on accepting the American proposal to participate in its dispute with China, the Chancellor said she was "very concerned" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "bad for the world economy and generates additional headwinds."

"It is my opinion there are areas where we need to challenge China, but there are also significant prospects to export to China's economy, including banking sector and other sectors of the economic system. We've got to maintain that equilibrium right."

The chancellor also affirmed she was collaborating with international partners "on our own critical minerals plan, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

Reeves also admitted that the price the National Health Service spends on drugs could increase as a result of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or scrapping investments in the UK, with some blaming the low prices they are receiving.

Last month, the government science advisor said the cost the NHS spends on drugs would have to rise to stop firms and drug research funding departing from the UK.

Reeves informed media: "We have seen due to the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to guarantee that people getting care from the National Health Service are able to obtain the top life-saving treatments in the world. And so we are reviewing all of that, and... aiming to obtain additional capital into the UK."